Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-12-23FDA Approved: OXYCODONE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for oxycodone hydrochloride from ANI Pharmaceuticals, indicating a new or updated ANDA product u…
-
FDA approval · 2025-12-23FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride by VistaPharm, LLC, enabling the marketing of the generic product in the…
-
FDA approval · 2025-12-23FDA Approved: TRAMADOL HYDROCHLORIDE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for tramadol hydrochloride from Advagen Pharma Limited under ANDA 208708, indicating an additional a…
-
FDA approval · 2025-12-23FDA Approved: OXYMORPHONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental ANDA for oxymorphone hydrochloride from Epic Pharma, LLC, authorizing a generic oxymorphone hydrochloride produc…
-
FDA approval · 2025-12-23FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for a hydrocodone bitartrate and acetaminophen product from Strides Pharma Science Limited, expa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-12-22FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (KVK-Tech, Inc.)
FDA approved a supplemental application for a generic oxycodone and acetaminophen product from KVK-Tech, Inc.
-
FDA approval · 2025-12-22FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for Hydrocodone Bitartrate and Acetaminophen, approving a generic analges…
-
FDA approval · 2025-12-22FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for BUTRANS (buprenorphine) from Purdue Pharma LP.
-
FDA approval · 2025-12-22FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for methadone hydrochloride in a generic product by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2025-12-22FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for MS CONTIN (morphine sulfate) submitted by Rhodes Pharmaceuticals L.P., resulting in an updat…
-
FDA approval · 2025-12-22FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Aurolife Pharma, LLC)
FDA approved a supplemental application for Aurolife Pharma’s methadone hydrochloride product, enabling its marketing as a generic methadone…
-
FDA approval · 2025-12-22FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Genus Lifesciences Inc.)
FDA approved a supplemental application for Hydrocodone Bitartrate and Acetaminophen from Genus Lifesciences Inc., enabling its marketing as…
-
FDA approval · 2025-12-22FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Granules Pharmaceuticals Inc.)
FDA approves Granules Pharmaceuticals Inc.'s supplemental application to market a generic oxycodone/acetaminophen product (ANDA 211708).
-
FDA approval · 2025-12-22FDA Approved: PROLATE — Supplemental Application (Forte Bio-Pharma LLC)
FDA approved a supplemental application for PROLATE (oxycodone hydrochloride and acetaminophen) from Forte Bio-Pharma LLC.
-
FDA approval · 2025-12-22FDA Approved: BELBUCA — Supplemental Application (BioDelivery Sciences International Inc)
The FDA approved a supplemental application for Belbuca (buprenorphine hydrochloride) from BioDelivery Sciences International Inc.
-
FDA approval · 2025-12-22FDA Approved: DISKETS — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for DISKETS (methadone hydrochloride) by Hikma Pharmaceuticals USA Inc. The approval expands the lab…
-
FDA approval · 2025-12-22FDA Approved: OLINVYK — Supplemental Application (Trevena, Inc.)
The FDA approved a supplemental application for OLINVYK (oliceridine) from Trevena, Inc. This action updates the product labeling as part of…
-
FDA approval · 2025-12-22FDA Approved: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for tramadol hydrochloride and acetaminophen from Micro Labs Limited.
-
FDA approval · 2025-12-22FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc)
FDA approved a supplemental application for Methadone Hydrochloride from Camber Pharmaceuticals, Inc, updating the product’s regulatory stat…
-
FDA approval · 2025-12-22FDA Approved: ACETAMINOPHEN AND CODEINE PHOSPHATE — Supplemental Application (Elite Laboratories, Inc.)
FDA approved a supplemental application for Acetaminophen and Codeine Phosphate from Elite Laboratories, Inc., for its analgesic combination…
-
FDA approval · 2025-12-22FDA Approved: BUPRENORPHINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for buprenorphine from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2025-12-22FDA Approved: DSUVIA — Supplemental Application (AcelRx Pharmaceuticals, Inc.)
FDA approved a supplemental application for DSUVIA (sufentanil) by AcelRx Pharmaceuticals, Inc., authorizing changes to the NDA. The approva…
-
FDA approval · 2025-12-22FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for butorphanol tartrate from Hikma Pharmaceuticals USA Inc., enabling the marketing of a generi…
-
FDA approval · 2025-12-22FDA Approved: MORPHINE SULFATE — Supplemental Application (Fresenius Kabi, USA LLC)
FDA approved a supplemental application for Morphine Sulfate submitted by Fresenius Kabi, USA LLC.
-
FDA approval · 2025-12-22FDA Approved: LEVORPHANOL TARTRATE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Levorphanol Tartrate submitted by SpecGx LLC.